Similarly, cervical cancer patients with positive TP53 expression also display smaller cumulative DFS rate (73.1%), compared with those with negative TP53 expression patients (92.3%, P = 0.006) (Fig. 4a, b). The gene discussed is TP53; the disease is cervical cancer.